DocDollars

Roche Products Limited

Great Britain (UK) · Reporting entity ID 100000010364

Total reported 2019–2025
$80.8M
#120 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.44M in general payments across 981 records, plus $79.4M in research funding across 19,482 records.

How it breaks down

General payments $1,444,273
Research funding $79,357,047

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Roche Products Limited reported $80.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #120 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 981 general payment records and 19,482 research records were filed.

Common questions about Roche Products Limited

How much has Roche Products Limited paid US doctors?

Roche Products Limited reported $80,801,320 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,444,273 in general payments, $79,357,047 in research funding.

How does Roche Products Limited rank among drug and device companies?

It ranks #120 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Roche Products Limited mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.